These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. Bendz D, Paxéus NA, Ginn TR, Loge FJ. J Hazard Mater; 2005 Jul 15; 122(3):195-204. PubMed ID: 15967274 [Abstract] [Full Text] [Related]
5. Adsorption, sedimentation, and inactivation of E. coli within wastewater treatment wetlands. Boutilier L, Jamieson R, Gordon R, Lake C, Hart W. Water Res; 2009 Sep 15; 43(17):4370-80. PubMed ID: 19595429 [Abstract] [Full Text] [Related]
7. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment. Strenn B, Clara M, Gans O, Kreuzinger N. Water Sci Technol; 2004 Sep 15; 50(5):269-76. PubMed ID: 15497857 [Abstract] [Full Text] [Related]
10. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments. MacLeod SL, Wong CS. Water Res; 2010 Jan 15; 44(2):533-44. PubMed ID: 19854463 [Abstract] [Full Text] [Related]
11. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Paxéus N. Water Sci Technol; 2004 Jan 15; 50(5):253-60. PubMed ID: 15497855 [Abstract] [Full Text] [Related]
12. Pharmaceutical pollution of water resources in Nakivubo wetlands and Lake Victoria, Kampala, Uganda. Dalahmeh S, Björnberg E, Elenström AK, Niwagaba CB, Komakech AJ. Sci Total Environ; 2020 Mar 25; 710():136347. PubMed ID: 31923689 [Abstract] [Full Text] [Related]
13. Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent. Matamoros V, García J, Bayona JM. Water Res; 2008 Feb 25; 42(3):653-60. PubMed ID: 17826819 [Abstract] [Full Text] [Related]
15. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Heberer T, Reddersen K, Mechlinski A. Water Sci Technol; 2002 Feb 25; 46(3):81-8. PubMed ID: 12227607 [Abstract] [Full Text] [Related]
16. Redox properties of a constructed wetland: theoretical and practical aspects. Síma J, Diáková K, Pavelcová L, Havelka M. Chem Biodivers; 2009 Mar 25; 6(3):341-55. PubMed ID: 19319861 [Abstract] [Full Text] [Related]
17. Occurrence and fate of benzothiazoles and benzotriazoles in constructed wetlands. Matamoros V, Jover E, Bayona JM. Water Sci Technol; 2010 Mar 25; 61(1):191-8. PubMed ID: 20057105 [Abstract] [Full Text] [Related]
18. Assessing the diurnal variability of pharmaceutical and personal care products in a full-scale activated sludge plant. Salgado R, Marques R, Noronha JP, Mexia JT, Carvalho G, Oehmen A, Reis MA. Environ Pollut; 2011 Oct 25; 159(10):2359-67. PubMed ID: 21783287 [Abstract] [Full Text] [Related]
19. Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms. Yan Q, Min J, Yu Y, Zhu Z, Feng G. Chemosphere; 2017 Nov 25; 186():823-831. PubMed ID: 28826130 [Abstract] [Full Text] [Related]
20. A constructed wetland model for synthetic reactive dye wastewater treatment by narrow-leaved cattails (Typha angustifolia Linn.). Nilratnisakorn S, Thiravetyan P, Nakbanpote W. Water Sci Technol; 2009 Nov 25; 60(6):1565-74. PubMed ID: 19759459 [Abstract] [Full Text] [Related] Page: [Next] [New Search]